全球生物制造产业关键平台设施建设现状分析与思考

Analysis and reflections on key platform facilities construction of global biomanufacturing industry

        吴晓燕¹(中国科学院成都文献情报中心 成都 610299)
        陈方¹(中国科学院成都文献情报中心 成都 610299)
        单耀莹²(中国科学院 可持续发展研究局 北京 100864)
        陆安静^3*(中国电子信息产业发展研究院 北京 100081)

         生物制造;生物产业;基础设施;中试平台;孵化平台

        biomanufacturing;bioindustry;infrastructure;pilot platform;incubation platform

        生物制造作为一种新兴的生产方式，逐渐成为全球经济发展的重要趋势，受到各国的高度重视。平台设施在生物制造产业的发展中扮演着关键角色，不仅是技术创新的基石，也是将科研成果转化为实际生产和市场应用的重要支撑。文章深入调研并分析了技术创新、中试放大和产业孵化3类关键平台设施的建设目标和运作机制，重点分析了美国敏捷生物工厂等技术创新平台、欧洲生物基地中试工厂等中试放大平台，以及英国合成生物学创新知识中心等产业孵化平台。通过借鉴这些平台的成功经验，结合我国平台设施建设的现状，从创新引领、平台支撑、模式优化、能力提升、生态构建、政策护航和人才培养等方面提出了发展建议。

        Biomanufacturing, an emerging production method, is becoming a significant trend in global economic development and has garnered widespread international attention. Platform facilities are vital to the biomanufacturing industry’s development, serving as both the foundation for technological innovation and the bridge between research outcomes and practical applications. This study analyzes three key types of platform facilities and their operational mechanisms: technology innovation platforms (exemplified by the U. S. Agile BioFoundry), pilot-scale platforms (represented by European Bio Base Europe Pilot Plant), and industry incubation platforms (illustrated by the UK SynbiCITE). Drawing from these successful examples and examining China’s current platform infrastructure, this paper presents development recommendations that address innovation leadership, platform support, model optimization, capability enhancement, ecosystem building, policy guidance, and talent cultivation.